Last reviewed · How we verify
NCT03719365: DPNAVA
Driving Pressure Variation: NAVA vs PSV
NA trial testing NAVAPSV in Mechanical Ventilation Complication in 20 participants. Status unknown.
1 December 2019
Quick facts
| Lead sponsor | Azienda Ospedaliero Universitaria Maggiore della Carita |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 20 |
| Start date | 1 November 2018 |
| Primary completion | 1 December 2019 |
| Estimated completion | 1 November 2020 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- NAVAPSV
Conditions studied
- Mechanical Ventilation Complication — all drugs for Mechanical Ventilation Complication →
- Ventilator-Induced Lung Injury — all drugs for Ventilator-Induced Lung Injury →
Sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita — full company profile →
Who can join
18 and older, any sex, with Mechanical Ventilation Complication or Ventilator-Induced Lung Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assisted ventilation represents, nowadays, the preferred ventilation mode in clinical practice.It has been shown that assisted ventilation modes improve ventilation/perfusion matching, descrease risk of Ventilator induced lung injury and muscle atrophy and have less influence on haemodynamic function. However, PSV (Pressure Support Ventilation) is not free from complications: it may worsen or cause lung injuries by increasing alveolar and intrathoracic negative pressure and by loosing control on Tidal Volume (Vt). Indeed, it has been demonstrated that Vt is the main factor related to VILI. It has been shown that lower Vt and higher PEEP can improve clinical outcome only if associated with a simultaneous reduction in Driving Pressure. Increase in Driving Pressure resulted strongly associated with negative outcomes, especially if higher than 15 cm H2O. PSV is currently the most used assisted ventilation mode. NAVA (Neurally Adjusted Ventilatory Assist) is a ventilation mode in which the diaphragmatic electrical activity (EAdi) is used as a trigger to start a mechanical breath, applying positive pressure during patient's inspiration. Diaphragmatic electrical activity (EAdi) can be detected by a particular nasogastric tube (EAdi catheter). EAdi is the currently available signal closest to the neural breathing centers, which can estimate the patient's respiratory drive, if phrenic nerves are not damaged. It has been demonstrated that NAVA ventilation can reduce the incidence of patient-ventilator asynchronies, because the delivery of the support and the cycling between inspiration and expiration are completely controlled by the patient. However, although PSV and NAVA have been widely compared in many investigations, up to now there are no studies about driving pressure variation during these two modalities of mechanical assisted ventilation. The aim of this study is to measure changes in driving pressure at different levels of ventilatory assistance in PSV and NAVA ventilation modes. Secondary end points are respiratory mechanics indices and patient/ventilator related asynchrony evaluation and comparison.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Varying Levels of Inspiratory Assistance with Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist on Driving Pressure in Patients Recovering from Hypoxemic Respiratory Failure.
Cammarota G, Verdina F, De Vita N, Boniolo E, et al · · 2022 · cited 6× · PMID 33559864 · DOI 10.1007/s10877-021-00668-2
Verify or expand the search:
- PubMed search for NCT03719365
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mechanical Ventilation Complication
Currently open trials in the same condition.
- NCT06921655 — Targeting prEssure-Muscle-index to Avoid Ventilatory Over-Assistance During Pressure Support Ventilation · NA · recruiting
- NCT07207772 — EIT-guided PEEP Titration Versus Standard Ventilation in Bariatric Surgery · NA · recruiting
- NCT07182851 — Prevalence of Pain in Mechanically Ventilated Patients in Intensive Care Units · recruiting
- NCT06575530 — Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients · Phase 4 · recruiting
- NCT06592144 — TESTO-TRIAL: Use of Testosterone in Critically Ill Patients · Phase 4 · active not recruiting
Other Azienda Ospedaliero Universitaria Maggiore della Carita trials
Trials by the same sponsor.
- NCT06542926 — NON-COlorectal Liver METastases Undergoing Liver Resection · not yet recruiting
- NCT05298891 — Hypoproteic Diet in Acromegaly · NA · unknown
- NCT06438900 — Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity · recruiting
- NCT06370507 — Monitoring of Lung Ventilation Through Electrical Impedance Tomography During Pediatric Surgery · not yet recruiting
- NCT06312280 — Evaluation of Body Composition in Pediatric Patients With Overweight or Obesity · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03719365 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero Universitaria Maggiore della Carita
- Last refreshed: 12 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03719365.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing